Upgrade to SI Premium - Free Trial

'Guardant Health (GH) is our top growth idea'; PT Lowered to $120 at TD Cowen

April 13, 2026 8:48 AM
TD Cowen analyst Dan Brennan lowered the price target on Guardant Health (NASDAQ: GH) to $120.00 (from $135.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change